Those people who take low-dose aspirin to prevent heart disease and stroke could be at risk of bleeding in the skull, a new report said. According to researchers, who analyzed data from 13 previous studies in which more than 130,000 people (ages 42 to 74) who didn’t have a history of heart disease or stroke were given low-dose aspirin or a placebo, people who took low-dose aspirin had a 0.63 percent risk of having a head bleed. Researchers said the percentage was the equivalent of an additional 2 out of every 1,000 people developing a bleed. Although low-dose aspirin was once recommended to prevent heart disease and stroke, other studies have concluded the practice is, at best, a waste of money for healthy older adults. At worst, people could raise their risk of internal bleeding and early death.

- More Content Now


Less cancer screenings ordered later in the day

According to a recent study conducted by the University of Pennsylvania, getting screened for cancer could depend on what time of day you visit the doctor. The study found that during the 8 a.m. hour, primary-care physicians ordered breast-cancer screenings for 64 percent of patients who were eligible, while the same doctors asked for the tests for 48 percent of eligible patients during the 5 p.m. hour. The study also found the same decline happened with colon cancer screenings as doctors ordered the tests 37 percent for the 8 a.m. hour, but 23 percent for the 5 p.m. hour.

- More Content Now


Avoid getting bit by a snake

As the weather continues to warm and people spend more time outdoors, there is an increase risk of snake bites. You can help protect yourself (and dog) from snake bites while outdoors by: Staying on the trail; keeping your dog on a leash; wear shoes that cover the entire foot and wear long pants.

- More Content Now


200,000: Gilead Sciences recently announced it will donate enough Truvada, a drug used to prevent HIV acquisition, to the U.S. Centers for Disease Control Prevention to supply 200,000 Americans for more than a decade.

- More Content Now